Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Hypothyroidism
Interventions: Not listed
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 17 Years to 44 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Mild Cognitive Impairment
Interventions: Neuro-World; Device
Lead sponsor: University of Massachusetts, Amherst; Other
Eligibility: 55 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Amherst, Massachusetts • Newark, New Jersey

Conditions: Meibomian Gland Dysfunction
Interventions: 2-3 Joule LED blue light device; Device
Lead sponsor: Toyos Clinic; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Germantown, Tennessee • Nashville, Tennessee

Conditions: Prostate Cancer
Interventions: Genistein, Placebo; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Left Ventricular Dysfunction, Spinal Anesthetics Causing Adverse Effects in Therapeutic Use, Global Cardiac Wall Motion Dysfunction
Interventions: Intrathecal local anesthesia; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Granulomatous Disease, Chronic, X-linked
Interventions: Lentiviral G1XCGD Gene Therapy; Biological
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 23 Months and older · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 3
States / cities: Los Angeles, California • Bethesda, Maryland • Boston, Massachusetts

Conditions: Traumatic Brain Injury, Chronic Traumatic Encephalopathy, Mild Cognitive Impairment
Interventions: Amyvid PET Scan, T807 PET scan; Drug
Lead sponsor: Samuel Gandy; Other
Eligibility: 40 Years to 85 Years · Male only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Living Alone, Alzheimer Disease, Mild Cognitive Impairment
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 55 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Coronary Artery Bypass Grafting, Mitral Valve Surgery, Low Cardiac Output Syndrome
Interventions: Levosimendan, Placebo; Drug
Lead sponsor: Tenax Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 882 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 49
States / cities: Burlington, Alabama • Huntsville, Alabama • Sacramento, California + 41 more

Conditions: Mild Cognitive Impairment, Amnestic Mild Cognitive Disorder, Deep Brain Stimulation, Mild Alzheimer's Disease
Interventions: Low-Intensity Focused Ultrasound Pulsation (LIFUP); Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 50 Years to 90 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Postoperative Gastrointestinal Dysfunction
Interventions: TAK-954 Placebo, TAK-954; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 19
States / cities: Mobile, Alabama • Los Angeles, California • Orange, California + 14 more

Conditions: HIV, Non-HIV, Vagus Nerve Dysfunction
Interventions: Pyridostigmine, Placebos, non-invasive vagal nerve stimulation; Drug · Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 215 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer Disease, Dementia Frontal, Mild Cognitive Impairment
Interventions: EEG scan; Device
Lead sponsor: Metabolic Therapy Inc.; Other
Eligibility: 60 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Mild Cognitive Impairment, Subjective Memory Impairment
Interventions: fatty acid/flavonoid blend, Placebo; Dietary Supplement
Lead sponsor: University of East Anglia; Other
Eligibility: 55 Years and older
Enrollment: 259 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Immunoglobulin A Nephropathy (IgAN)
Interventions: zigakibart; Biological
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 5
States / cities: San Francisco, California • Denver, Colorado • Acworth, Georgia + 2 more

Conditions: Traumatic Brain Injury, Upper Extremity Dysfunction, Disability Physical
Interventions: HAHE, Exergame; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 45 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Binocular Vision Dysfunction, Vertical Heterophoria
Interventions: Questionnaires and Optometrist Prism Challenge/Treatment; Other
Lead sponsor: Vision Specialists of Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Bloomfield Hills, Michigan • Livonia, Michigan

Conditions: Post-operative Delirium, Decision Support Systems, Clinical, Cognitive Impairment
Interventions: Clinical Decision Support; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 120 Years
Enrollment: 7,412 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Brain Injuries, Traumatic, Executive Dysfunction
Interventions: Home-based telehealth GOALS, In-person GOALS; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 65 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Adolescent Idiopathic Scoliosis, Neuromuscular Scoliosis, Perioperative/Postoperative Complications, Iron Deficiencies, Anemia, Spinal Fusion, Postoperative Cognitive Dysfunction
Interventions: Oral ferrous sulfate, Oral placebo tablet; Dietary Supplement
Lead sponsor: Columbia University; Other
Eligibility: 10 Years to 26 Years
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Pediatric Feeding Disorder, Chronic, Pediatric Feeding Dysfunction, Acute
Interventions: Parent Acceptance and Commitment Therapy (PACT), Control; Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Polycystic Ovary Syndrome (PCOS)
Interventions: Flutamide, Placebo; Drug · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Type 1 Diabetes Mellitus
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Mild Cognitive Impairment, Cognitive Impairment
Interventions: Insulin, Placebo, intranasal nebulizer-like device; Drug · Other · Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Search by objective public record fields.

Maternal Hypothyroidism in Pregnancy

Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

Efficacy and Safety of Meibomian Gland Dysfunction and Dry Eye With an LED Blue Treatment Device

Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer

Effects of Intrathecal Local Anesthetics on Left Ventricular Global Longitudinal Strain

Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease

Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury

Living Alone in Old Age With Cognitive Impairment

Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass

Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease

A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery

Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

Evidence Amyloid Scan EEG Study

The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

TeleRehab to Restore Upper Limb Function in People With Chronic TBI

Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria

Mitigation of Postoperative Delirium in High-Risk Patients

GOALS Cognitive Training Delivered to Aging Veterans in Person or Via Telehealth

Kids With Iron Deficiency and Scoliosis

Parent Acceptance and Commitment Therapy (PACT) for Parents of Children With Pediatric Feeding Disorder

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

To Evaluate if Wide Blood Sugar Fluctuations Lead to Injury of Heart Function and Heart Nerves

Study of Nasal Insulin to Fight Forgetfulness - Device Study